Member Info for Mulder

Yes you are correct. Mediclinic were being very stingy with their cash offer and have scored a bad own goal.

Hate to say it Fruitster but the shorts seem to be targeting 32p near term and it looks on - possibly ex-dividend. As I said before they seemingly have total control and manipulation of an SP and the FCA do not care one bit. 32p would give a P/E of just 5; hell even if profits halved the P/E would only be 10. As for 75p yes I came to that as the book value but I have to be fair and say that includes a lot of intangibles/goodwill whose true worth is anybody's guess. As for Ashley again whenever his actual shareholding goes up/converts the SP drops alarmingly. Only he knows what his intentions are.

A �1M buy might mean something. Rather cynical now about these small director buys in relation to the fat cats' huge salaries.

The restructuring costs/one off costs are not very clear in the results.

The big drop pre-results smells very bad. Blatant leak and insider trading IMO. Trying to be balanced here. Am I correct in saying UK is now no longer loss making? Adjusted EBITDA £1M for UK If so then the results are misleading as profits rather than being flat were +£10M Drop in international profits concerning but may rebound if oil prices continue to recover? Thoughts?

Care to elaborate on this? Like your positivity on a difficult day.

You were long on Centrica I believe. Views after another big crash today?!

Resulting situation on the date on which threshold was crossed or reached 5.11% 5.02% 10.13%

Out of the ones you listed I am in DEB obviously but also: - 1. M&S (P/E around 10 and I reckon a take over candidate/Middle East buyer) 2. Centrica (again P/E approx 10 and yield if not cut >7% but not a big fan of its balance sheet - a lot of intangibles similar to here - not sure what you make of it) Sold out of RMG only today as the strikes will likely go ahead after Xmas GSK's balance sheet was surprisingly bad when I looked at it with high debt, net equity of only �5Bn and a book price of barely a pound. BT - avoided due to pension issues again and a poor balance sheet. It is annoying and a disgrace how the market will forget about pension deficits and debt for years and then will suddenly 'remember' - BT and GSK being classic examples. Hammered this year for long standing issues. Utility sector looks cheap at the moment and supposedly 'defensive'. DRAX is an interesting one trading at half its NAV - you may want to look at it. WPP, ITV, Kingfisher, Whitbread all trading at multi year lows and P/E's around 10.

What's your view on how the market places a ridiculously high premium on the word 'growth' and vice versa. A flat profit or slight decline is often met with a gross over reaction and decline in SP. Pharma stocks like BTG and Abcam on P/E's of 80 (!) SSPG on a P/E of 33 but still surging. A solid defensive like United Utilities now on a P/E of under 13 yet still falling. At some point the market wakes up.

Thanks. So basically he is not shorting this. Looks like shorts are targeting 32p whilst making a mockery of the fundamentals here.

Just an example Whitbread - a �7Bn giant compared to this - is trading on a P/E of just 12 with the prospect of further growth in China and Germany. Whitbread also has minimal intangibles/goodwill with equity of �2.7Bn and is trading at just 2x its book price. Same P/E (33) as here and Whitbread's share price would be around 10000p not 3500p Like I said - the market is rogue and corrupt.

So a very high P/E of 33 here and yet the SP continues to rise. Some far larger companies trading on P/E's between 5-10, below their book value/NAV and still getting hammered. Poor balance sheet also here with net assets of �465M but a stonking Intangibles/goodwill figure of �714M Take these out and you have negative equity of -�250M Trading at 8x book value Yep the market certainly has their favourites. Based on fundamentals this should not be trading much above 300p which still allows for a generous P/E of 15 and some 'growth'

Good to see you back in here. I did manage to sell some around �3 in case the bid fell through which I did not expect but one can never trust the market and this proved to be the case again. Mediclinic missed a great opportunity IMO and messed up big time. Private healthcare will only rise as will the SP here.

Strange how this has barely moved even though results were good and SVT + PNN are up strongly. Could something else be going on here? Someone accumulating at rock bottom prices? Possible.

Ashley's put options are said to be rather vague and not well understood. Every time his derivative converts to shares the SP seems to drop. I read somewhere he may even be shorting this - is that possible?

Roche also up today so rise not Roche related I would guess.

RSI 19

Re-iterates...

.